Human papillomavirus genome variants

Virology

Volumn 445, Issue 1-2, 2013, Pages 232-243

  Burk, Robert D ^a   Harari, Ariana ^a   Chen, Zigui ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alphapapillomaviruses; HPV; HPV evolution; HPV variant lineages; Human papillomavirus variants

Indexed keywords

ADENOCARCINOMA; ALPHAPAPILLOMAVIRUS; ARTICLE; BETAPAPILLOMAVIRUS; DISEASE ASSOCIATION; DNA SEQUENCE; GAMMAPAPILLOMAVIRUS; GENETIC ANALYSIS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 85; HUMAN PAPILLOMAVIRUS TYPE 97; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; PRECANCER; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CLASSIFICATION; VIRUS GENOME;

ALPHAPAPILLOMAVIRUSES; HPV; HPV EVOLUTION; HPV VARIANT LINEAGES; HUMAN PAPILLOMAVIRUS VARIANTS;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; UTERINE CERVICAL NEOPLASMS;

ALPHAPAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84884355784     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.07.018     Document Type: Article

References (89)

1. Alizon S., Luciani F., Regoes R.R. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol. 2011, 19:24-32.
2. Arias-Pulido H., Peyton C.L., Torrez-Martinez N., Anderson D.N., Wheeler C.M. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 2005, 338:22-34.
3. Barzon L., Militello V., Lavezzo E., Franchin E., Peta E., Squarzon L., Trevisan M., Pagni S., Dal Bello F., Toppo S., Palu G. Human papillomavirus genotyping by 454 next generation sequencing technology. J. Clin. Virol. 2011, 52:93-97.
4. Bennett M.D., Reiss A., Stevens H., Heylen E., Van Ranst M., Wayne A., Slaven M., Mills J.N., Warren K.S., O'Hara A.J., Nicholls P.K. The first complete papillomavirus genome characterized from a marsupial host: a novel isolate from Bettongia penicillata. J. Virol. 2010, 84:5448-5453.
5. Bernard H.U. Coevolution of papillomaviruses with human populations. Trends Microbiol. 1994, 2:140-143.
6. Bernard H.U. Taxonomy and phylogeny of papillomaviruses: An overview and recent developments. Infect. Genet. Evol. 2013, 18:357-361.
7. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
8. Bernard H.U., Calleja-Macias I.E., Dunn S.T. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int. J. Cancer 2006, 118:1071-1076.
9. Bernard H.U., Chan S.Y., Delius H. Evolution of papillomaviruses. Curr. Top. Microbiol. Immunol. 1994, 186:33-54.
10. Berumen J., Ordonez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 93:1325-1330.
11. Bottalico D., Chen Z., Dunne A., Ostoloza J., McKinney S., Sun C., Schlecht N.F., Fatahzadeh M., Herrero R., Schiffman M., Burk R.D. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J. Infect. Dis. 2011, 204:787-792.
12. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009, 10:321-322.
13. Burk R.D. Pernicious papillomavirus infection. N. Engl. J. Med. 1999, 341:1687-1688.
14. Burk R.D., Chen Z., Harari A., Smith B.C., Kocjan B.J., Maver P.J., Poljak M. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerologica Alp., Panonica, Adriat. 2011, 20:113-123.
15. Burk R.D., Chen Z., Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 2009, 12:281-290.
16. Burk R.D., Terai M., Gravitt P.E., Brinton L.A., Kurman R.J., Barnes W.A., Greenberg M.D., Hadjimichael O.C., Fu L., McGowan L., Mortel R., Schwartz P.E., Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003, 63:7215-7220.
17. Calleja-Macias I.E., Kalantari M., Huh J., Ortiz-Lopez R., Rojas-Martinez A., Gonzalez-Guerrero J.F., Williamson A.L., Hagmar B., Wiley D.J., Villarreal L., Bernard H.U., Barrera-Saldana H.A. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004, 319:315-323.
18. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.I., Bosch F.X., Munoz N., Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 2005, 79:13630-13640.
19. Chan P.K., Zhang C., Park J.S., Smith-McCune K.K., Palefsky J.M., Giovannelli L., Coutlee F., Hibbitts S., Konno R., Settheetham-Ishida W., Chu T.Y., Ferrera A., Alejandra Picconi M., De Marco F., Woo Y.L., Raiol T., Pina-Sanchez P., Bae J.H., Wong M.C., Chirenje M.Z., Magure T., Moscicki A.B., Fiander A.N., Capra G., Young Ki.E., Tan Y., Chen Z., Burk R.D., Chan M.C., Cheung T.H., Pim D., Banks L. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int. J. Cancer 2013, 132:2528-2536.
20. Chan S.Y., Chew S.H., Egawa K., Grussendorf-Conen E.I., Honda Y., Rubben A., Tan K.C., Bernard H.U. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology 1997, 239:296-302.
21. Chang Y.J., Chen H.C., Lee B.H., You S.L., Lin C.Y., Pan M.H., Chou Y.C., Hsieh C.Y., Chen Y.M., Cheng Y.J., Chen C.J., Group C.-H.S. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int. J. Cancer 2011, 129:965-973.
22. Chen Z., DeSalle R., Schiffman M., Herrero R., Burk R.D. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J. Virol. 2009, 83:1443-1455.
23. Chen Z., Schiffman M., Herrero R., Desalle R., Anastos K., Segondy M., Sahasrabuddhe V.V., Gravitt P.E., Hsing A.W., Burk R.D. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011, 6:e20183.
24. Chen Z., Schiffman M., Herrero R., Desalle R., Anastos K., Segondy M., Sahasrabuddhe V., Gravitt P.E., Hsing A., Burk R.D. Evolution and taxonomic classification of Alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One 2013, 8(8): e72565, 10.1371/journal.pone.0072565.
25. Chen Z., Terai M., Fu L., Herrero R., DeSalle R., Burk R.D. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J. Virol. 2005, 79:7014-7023.
26. Conway C., Chalkley R., High A., Maclennan K., Berri S., Chengot P., Alsop M., Egan P., Morgan J., Taylor G.R., Chester J., Sen M., Rabbitts P., Wood H.M. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J. Mol. Diagnostics 2012, 14:104-111.
27. Cornet I., Gheit T., Franceschi S., Vignat J., Burk R.D., Sylla B.S., Tommasino M., Clifford G.M., Group I.H.V.S. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 2012, 86:6855-6861.
28. Cornet I., Gheit T., Clifford G.M., Combes J.D., Dalstein V., Franceschi S., Tommasino M., Clavel C. Human papillomavirus type 16 E6 variants in France and risk of viral persistence. Infect. Agents Cancer 2013, 8;:4.
29. Cornet I., Gheit T., Iannacone M.R., Vignat J., Sylla B.S., Del Mistro A., Franceschi S., Tommasino M., Clifford G.M. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 2013, 108:240-244.
30. de Araujo Souza P.S., Sichero L., Maciag P.C. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol. 2009, 5:359-370.
31. De Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., Jordanova E.S., Fleuren G.J. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int. J. Cancer 2005, 114:422-425.
32. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
33. de Villiers E.M., Gissmann L., zur Hausen H. Molecular cloning of viral DNA from human genital warts. J. Virol. 1981, 40:932-935.
34. Deau M.C., Favre M., Jablonska S., Rueda L.A., Orth G. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J. Clin. Microbiol. 1993, 31:2918-2926.
35. Deau M.C., Favre M., Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 1991, 184:492-503.
36. Edgar R.C. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004, 5:113.
37. Ekstrom J., Bzhalava D., Svenback D., Forslund O., Dillner J. High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions. Int. J. Cancer 2011, 129:2643-2650.
38. Formentin A., Archambault J., Koushik A., Richardson H., Brassard P., Franco E.L., Coutlee F. Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix. Int. J. Cancer 2013, 132:1821-1830.
39. Gheit T., Cornet I., Clifford G.M., Iftner T., Munk C., Tommasino M., Kjaer S.K. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1315-1321.
40. Giannoudis A., Herrington C.S. Human papillomavirus variants and squamous neoplasia of the cervix. J. Pathol. 2001, 193:295-302.
41. Gottschling M., Stamatakis A., Nindl I., Stockfleth E., Alonso A., Bravo I.G. Multiple evolutionary mechanisms drive papillomavirus diversification. Mol. Biol. Evol. 2007, 24:1242-1258.
42. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjose S., Franceschi S., Clifford G.M. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 2012, 131:2349-2359.
43. Hecht J.L., Kadish A.S., Jiang G., Burk R.D. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer 1995, 60:369-376.
44. Heinzel P.A., Chan S.Y., Ho L., O'Connor M., Balaram P., Campo M.S., Fujinaga K., Kiviat N., Kuypers J., Pfister H., et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J. Clin. Microbiol. 1995, 33:1746-1754.
45. Herbst L.H., Lenz J., Van Doorslaer K., Chen Z., Stacy B.A., Wellehan J.F., Manire C.A., Burk R.D. Genomic characterization of two novel reptilian papillomaviruses, Chelonia mydas papillomavirus 1 and Caretta caretta papillomavirus 1. Virology 2009, 383:131-135.
46. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M.C., Sherman M.E., Scarpidis U., Lin Q.Q., Terai M., Bromley R.L., Buetow K., Apple R.J., Burk R.D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 2001, 93:315-318.
47. Hildesheim A., Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002, 89:229-240.
48. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle J.P., Kahn T., Kiviat N., Lancaster W., Mavromara-Nazos P., Labropoulou V., Mitrani-Rosenbaum S., Norrild B., Pillai M.R., Stoerker J., Syrjaenen K., Syrjaenen S., Tay S.K., Villa L.L., Wheeler C.M., Williamson A.L., Bernard H.U. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 1993, 67:6413-6423.
49. Ho L., Chan S.Y., Chow V., Chong T., Tay S.K., Villa L.L., Bernard H.U. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 1991, 29:1765-1772.
50. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: Cancer J. Clin. 2011, 61:69-90.
51. Kim Y.W., Bae S.M., Kim Y.W., Park D.C., Lee K.H., Liu H.B., Kim I.W., Jang C.K., Ahn W.S. Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma. Int. J. Oncol. 2013, 43:539-547.
52. Kohler A., Gottschling M., Manning K., Lehmann M.D., Schulz E., Kruger-Corcoran D., Stockfleth E., Nindl I. Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients. J. Gen. Virol. 2011, 92:1585-1594.
53. Li J., Cai H., Xu Z., Wang Q., Hang D., Shen N., Liu M., Zhang C., Abliz A., Ke Y. Nine complete genome sequences of cutaneous human papillomavirus genotypes isolated from healthy skin of individuals living in rural he nan province, China. J. Virol. 2012, 86:11936.
54. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int. J. Cancer 2011, 128:927-935.
55. Lizano M., Berumen J., Garcia-Carranca A. HPV-related carcinogenesis: basic concepts, viral types and variants. Arch. Med. Res. 2009, 40:428-434.
56. Luhn P., Walker J., Schiffman M., Zuna R.E., Dunn S.T., Gold M.A., Smith K., Mathews C., Allen R.A., Zhang R., Wang S., Wentzensen N. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol. Oncol. 2013, 128:265-270.
57. Matos R.P., Sichero L., Mansur I.M., Bonfim C.M., Bittar C., Nogueira R.L., Kupper D.S., Valera F.C., Nogueira M.L., Villa L.L., Rahal P., Calmon M.F. Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil. Infect. Genet. Evol. 2013, 16:282-289.
58. Mokili J.L., Dutilh B.E., Lim Y.W., Schneider B.S., Taylor T., Haynes M.R., Metzgar D., Myers C.A., Blair P.J., Nosrat B., Wolfe N.D., Rohwer F. Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness. PLoS One 2013, 8:e58404.
59. Mounts P., Shah K.V., Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA 1982, 79:5425-5429.
60. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
61. Ong C.K., Chan S.Y., Campo M.S., Fujinaga K., Mavromara-Nazos P., Labropoulou V., Pfister H., Tay S.K., ter Meulen J., Villa L.L., Bernard H.U. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 1993, 67:6424-6431.
62. Prado J.C., Calleja-Macias I.E., Bernard H.U., Kalantari M., Macay S.A., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Ortiz-Lopez R., Barrera-Saldana H.A., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Sanchez G.I., Bosch F.X., Villa L.L. Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 2005, 340:95-104.
63. Quint K.D., de Koning M.N., van Doorn L.J., Quint W.G., Pirog E.C. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecol. Oncol. 2010, 117:297-301.
64. Rector A., Lemey P., Tachezy R., Mostmans S., Ghim S.J., Van Doorslaer K., Roelke M., Bush M., Montali R.J., Joslin J., Burk R.D., Jenson A.B., Sundberg J.P., Shapiro B., Van Ranst M. Ancient papillomavirus-host co-speciation in Felidae. Genome Biol. 2007, 8:R57.
65. Sabol I., Matovina M., Si-Mohamed A., Grce M. Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants. PLoS One 2012, 7:e41045.
66. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
67. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C., Bratti M.C., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Wright T.C., Solomon D., Chen Z., Schussler J., Castle P.E., Burk R.D. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005, 337:76-84.
68. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
69. Schiffman M., Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol. Biomarkers Prev. 2013, 22:553-560.
70. Seedorf K., Krammer G., Durst M., Suhai S., Rowekamp W.G. Human papillomavirus type 16 DNA sequence. Virology 1985, 145:181-185.
71. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 2007, 120:1763-1768.
72. Sichero L., Villa L.L. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz. J. Med. Biol. Res. 2006, 39:707-717.
73. Smith B., Chen Z., Reimers L., van Doorslaer K., Schiffman M., Desalle R., Herrero R., Yu K., Wacholder S., Wang T., Burk R.D. Sequence imputation of HPV16 genomes for genetic association studies. PLoS One 2011, 6:e21375.
74. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., Clifford G.M. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 2007, 121:621-632.
75. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006, 22:2688-2690.
76. Stewart A.C., Eriksson A.M., Manos M.M., Munoz N., Bosch F.X., Peto J., Wheeler C.M. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 1996, 70:3127-3136.
77. Sun M., Gao L., Liu Y., Zhao Y., Wang X., Pan Y., Ning T., Cai H., Yang H., Zhai W., Ke Y. Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central china. PloS One 2012, 7:e36577.
78. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
79. Terai M., DeSalle R., Burk R.D. Lack of canonical E6 and E7 open reading frames in bird papillomaviruses: Fringilla coelebs papillomavirus and Psittacus erithacus timneh papillomavirus. J. Virol. 2002, 76:10020-10023.
80. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E.L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 2000, 81:2959-2968.
81. Wheeler C.M. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet. Gynecol. Clin. North Am. 2008, 35(vii):519-536.
82. Xi L.F., Kiviat N.B., Hildesheim A., Galloway D.A., Wheeler C.M., Ho J., Koutsky L.A. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl. Cancer Inst. 2006, 98:1045-1052.
83. Xi L.F., Koutsky L.A., Hildesheim A., Galloway D.A., Wheeler C.M., Winer R.L., Ho J., Kiviat N.B. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomarkers Prev. 2007, 16:4-10.
84. Xi L.F., Schiffman M., Koutsky L.A., He Z., Winer R.L., Hulbert A., Lee S.K., Ke Y., Kiviat N.B. Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage. Int. J. Cancer 2013, 132:549-555.
85. Xi L.F., Schiffman M., Koutsky L.A., Hulbert A., Lee S.K., Defilippis V., Shen Z., Kiviat N.B. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Int. J. Cancer 2012, 131:2300-2307.
86. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., Wheeler C.M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 1997, 71:2463-2472.
87. Yamada T., Wheeler C.M., Halpern A.L., Stewart A.C., Hildesheim A., Jenison S.A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 1995, 69:7743-7753.
88. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M., Blakey G.L., Teel T. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 2009, 125:2609-2613.
89. Zuna R.E., Tuller E., Wentzensen N., Mathews C., Allen R.A., Shanesmith R., Dunn S.T., Gold M.A., Wang S.S., Walker J., Schiffman M. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infect. Agents Cancer 2011, 6;:19.